Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
Intelligent Bio Solutions (Nasdaq: INBS) reported successful expansion of its fingerprint drug testing technology across Scandinavia through its partnership with Spjotgard. The company's Drug Screening System, which delivers results in under 10 minutes using fingerprint sweat, has gained traction across 450 accounts in 24 countries.
The technology is being adopted across various sectors including logistics, construction, warehousing, education, and criminal justice. Spjotgard, founded in 2021, has established a strong presence in Sweden, Norway, and Denmark, with growing interest in Finland. The system offers advantages over traditional drug testing methods, providing a non-invasive, hygienic, and efficient solution for workplace safety and education sectors.
Intelligent Bio Solutions (Nasdaq: INBS) ha annunciato l'espansione con successo della sua tecnologia di test antidroga tramite impronta digitale in Scandinavia, grazie alla partnership con Spjotgard. Il Drug Screening System dell'azienda, che fornisce risultati in meno di 10 minuti utilizzando il sudore delle impronte digitali, ha ottenuto diffusione in 450 clienti in 24 paesi.
La tecnologia viene adottata in diversi settori, tra cui logistica, edilizia, magazzinaggio, istruzione e giustizia penale. Spjotgard, fondata nel 2021, ha consolidato una presenza significativa in Svezia, Norvegia e Danimarca, con un interesse crescente in Finlandia. Il sistema offre vantaggi rispetto ai metodi tradizionali di test antidroga, proponendo una soluzione non invasiva, igienica ed efficiente per la sicurezza sul lavoro e il settore educativo.
Intelligent Bio Solutions (Nasdaq: INBS) informó la exitosa expansión de su tecnología de detección de drogas mediante huellas dactilares en Escandinavia a través de su asociación con Spjotgard. El Sistema de Detección de Drogas de la compañía, que ofrece resultados en menos de 10 minutos utilizando el sudor de las huellas digitales, ha ganado terreno en 450 cuentas en 24 países.
La tecnología se está adoptando en diversos sectores como logística, construcción, almacenamiento, educación y justicia penal. Spjotgard, fundada en 2021, ha establecido una fuerte presencia en Suecia, Noruega y Dinamarca, con un interés creciente en Finlandia. El sistema ofrece ventajas sobre los métodos tradicionales de detección de drogas, proporcionando una solución no invasiva, higiénica y eficiente para la seguridad laboral y el sector educativo.
Intelligent Bio Solutions (나스닥: INBS)는 Spjotgard와의 파트너십을 통해 스칸디나비아 전역에서 지문 약물 검사 기술의 성공적인 확장을 보고했습니다. 회사의 약물 스크리닝 시스템은 지문 땀을 사용하여 10분 이내에 결과를 제공하며, 24개국 450개 계정에서 인기를 얻고 있습니다.
이 기술은 물류, 건설, 창고, 교육 및 형사 사법 등 다양한 분야에서 채택되고 있습니다. 2021년에 설립된 Spjotgard는 스웨덴, 노르웨이, 덴마크에서 강력한 입지를 구축했으며 핀란드에서도 관심이 증가하고 있습니다. 이 시스템은 전통적인 약물 검사 방법에 비해 비침습적이고 위생적이며 효율적인 직장 안전 및 교육 부문 솔루션을 제공합니다.
Intelligent Bio Solutions (Nasdaq : INBS) a annoncé l'expansion réussie de sa technologie de dépistage de drogues par empreinte digitale en Scandinavie grâce à son partenariat avec Spjotgard. Le Système de Dépistage de Drogues de la société, qui fournit des résultats en moins de 10 minutes en utilisant la sueur des empreintes digitales, a gagné du terrain auprès de 450 comptes dans 24 pays.
La technologie est adoptée dans divers secteurs tels que la logistique, la construction, l'entreposage, l'éducation et la justice pénale. Fondée en 2021, Spjotgard a établi une forte présence en Suède, Norvège et Danemark, avec un intérêt croissant en Finlande. Le système offre des avantages par rapport aux méthodes traditionnelles de dépistage, proposant une solution non invasive, hygiénique et efficace pour la sécurité au travail et le secteur éducatif.
Intelligent Bio Solutions (Nasdaq: INBS) meldete die erfolgreiche Ausweitung seiner Fingerabdruck-Drogentests-Technologie in Skandinavien durch die Partnerschaft mit Spjotgard. Das Drug Screening System des Unternehmens, das Ergebnisse in unter 10 Minuten mittels Fingerabdruckschweiß liefert, hat in 450 Konten in 24 Ländern an Bedeutung gewonnen.
Die Technologie wird in verschiedenen Branchen eingesetzt, darunter Logistik, Bauwesen, Lagerhaltung, Bildung und Strafjustiz. Spjotgard, gegründet 2021, hat eine starke Präsenz in Schweden, Norwegen und Dänemark aufgebaut und verzeichnet wachsendes Interesse in Finnland. Das System bietet Vorteile gegenüber herkömmlichen Drogentests und stellt eine nicht-invasive, hygienische und effiziente Lösung für die Sicherheit am Arbeitsplatz und im Bildungsbereich dar.
- Established presence in 450 accounts across 24 countries
- Strong market penetration in Scandinavia through strategic partnership with Spjotgard
- Rapid 10-minute results delivery through non-invasive fingerprint testing
- Growing adoption across multiple sectors including logistics, construction, and education
- None.
Insights
INBS's fingerprint drug testing partnership with Spjotgard shows strong Scandinavian adoption, extending its global reach to 450+ accounts across 24 countries.
Intelligent Bio Solutions' strategic partnership with Spjotgard is delivering meaningful market penetration across Scandinavia's drug testing market. The collaboration has successfully positioned INBS's fingerprint-based drug screening technology in Sweden, Norway, and Denmark, with emerging opportunities in Finland.
The technology's key competitive advantages are resonating strongly in these markets:
- Non-invasive collection method using fingerprint sweat
- Rapid results in under 10 minutes
- Elimination of observed sample collection
- Comparable accuracy to traditional methods
This regional success is part of INBS's broader global footprint, now spanning over 450 accounts across 24 countries. The company has strategically targeted multiple sectors including logistics, construction, warehousing, education, and criminal justice – diversifying revenue streams and reducing sector-specific risks.
Spjotgard's pharmaceutical expertise and regional connections are proving valuable for market development. Their strategic collaborations with providers of complementary services (drug-detection dogs, alcohol testing) create natural sales channels and reinforce INBS's technology as part of comprehensive substance testing solutions.
The technology addresses specific regional needs, particularly in Sweden where concerns about drug driving and youth drug misuse are driving demand for more proactive testing approaches. The planned aggressive targeting of Norway indicates a structured geographic expansion strategy based on market readiness and regulatory environment.
The partnership demonstrates INBS's effective go-to-market strategy of utilizing specialized regional distributors rather than building direct sales infrastructure in each territory – a capital-efficient approach to international expansion in the medical technology sector.
With over 450 accounts across 24 countries, INBS continues to advance the evolution of drug screening technology
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening solutions, today announced the success of its ongoing partnership with Spjotgard, an established distributor serving the Scandinavian market. The collaboration is accelerating the adoption of the Intelligent Fingerprinting Drug Screening System across Sweden, Norway, and Denmark, with a growing interest in Finland.
Spjotgard, founded in 2021 by a team with deep pharmaceutical expertise, has rapidly developed a strong regional footprint, positioning INBS' fingerprint drug testing technology as its flagship solution in response to rising demand for modern, dignified approaches to drug testing.
"From the very beginning, we've seen strong interest in fingerprint-based testing across the region," said Hans Svensson, joint owner of Spjotgard. "Traditional methods like saliva and urine are still common, but our customers, especially in workplace safety and education, are seeking more hygienic, easy to use and less invasive alternatives. Fingerprint drug testing delivers that while delivering comparable levels of accuracy, saving time and reducing disruption."
INBS’ Drug Screening System is primarily used for random testing, post-incident investigations, and for-cause testing scenarios. Customers appreciate its simplicity and reduced discomfort compared to traditional urine tests, which require invasive observation. INBS’ Drug Screening System is used across logistics, construction, warehousing, education, and the criminal justice sector. In Sweden, growing concern about drug driving incidents and drug misuse among youth is leading organizations to explore more proactive testing strategies.
Spjotgard's presence in the region continues to expand through strategic collaborations with providers of drug-detection dogs and alcohol testing services. This includes a partner that has manufactured and sold evidential alcohol testing instruments to judicial authorities, primarily in the Nordic countries, as well as entry systems for companies with automatic alcohol checks. Spjotgard is actively engaged in customer demonstrations and industry events, primarily in Sweden. Spjotgard sees significant potential in Norway and plans to aggressively target this region in the months ahead.
"Scandinavia is setting a high standard in progressive drug testing policy, particularly Sweden, which is often seen as a model for neighboring countries," said Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions. "Spjotgard's strong market knowledge and trusted relationships make them a valuable partner as we continue to scale across Northern Europe."
INBS' Drug Screening System enables rapid, on-site drug screening using fingerprint sweat, with results delivered in under 10 minutes. Unlike traditional methods that require supervision, third-party administration, or removing staff from the job, INBS' Drug Screening System offers a discreet and efficient solution that is quickly gaining favor among HR teams, health and safety managers, and union representatives in Scandinavia.
With over 450 accounts across 24 countries, INBS continues to advance the evolution of drug screening technology. INBS and Spjotgard are driving a global shift towards more progressive, dignified, and effective drug testing solutions that satisfy the needs of employers in Scandinavia and beyond.
About Spjotgard
Spjotgard is a Scandinavian distributor of workplace drug testing solutions, operating across Sweden, Norway, and Denmark. Founded in 2021 by five part-owners, the company offers strategic solutions to meet the safety and compliance needs of employers, educational institutions, and public sector agencies throughout the region.
As a dynamic start-up, Spjotgard is dedicated to marketing and distributing innovative, high-quality, and market-leading products. Its carefully selected portfolio includes life science solutions and high-tech products for targeted sectors. With a blend of strategic insight and technical expertise, Spjotgard is positioned to deliver exceptional value to its partners and customers.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
For more information, visit: https://www.ibs.inc
Forward-Looking Statements:
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.'s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including "believes," "estimates," "anticipates," "expects," "plans," "projects," "intends," "potential," "may," "could," "might," "will," "should," "approximately" or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions' public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
FAQ
What is the current market reach of Intelligent Bio Solutions (INBS) drug testing technology?
How long does the INBS Drug Screening System take to deliver results?
Which industries are adopting INBS's fingerprint drug testing technology?
What are the advantages of INBS's fingerprint drug testing over traditional methods?
How is Spjotgard expanding INBS's presence in Scandinavia?
